Skip to main content

Our Initiatives

MNPQC is working with community partners and leaders to improve outcomes in the following areas. Our initiatives are reviewed and recommended by the Program Advisory Committee based on the needs of Minnesota families, evidence-based research, and the ability to make sustainable change.


Mother/Infant Opioid Substance Use Treatment and Recovery Effort

The MOSTaRE Initiative will: Emphasize family-centered care that maintains the maternal-infant dyad Address treatment and prevention of substance exposure during pregnancy for mother and infant Started September 2022 is open to all Minnesota birthing facilities and an ongoing enrollment. Engagement will include monthly action calls (available only to hospital teams) and monthly ECHO calls available to all. This project will satisfy new CMS guidelines for hospitals to collaborate with state PQCs. Tentative 2nd Cohort to start late 2023 early 2024. Hospitals interested will receive an orientation packet with details. 

For more information, please contact Ella Rusnacko

EHDI: Timely Diagnosis Initiative

Early Hearing Detection and Intervention (EHDI)

This Initiative was implemented in February 2023. The Aim is to improve the percentage of newborns with refer/did not pass newborn hearing screening from birthing facilities and received a complete audiological hearing evaluation by 3 months of age.

Hypertension in Pregnancy

In 2021 MNPQC hosted a statewide quality improvement initiative to improve the identification, treatment, and follow up of hypertension in pregnancy and the postpartum period. Information/resources on this work is found here.

Preterm Birth Prevention

Prematurity is now the leading cause of infant death in Minnesota and is associated with 33.1% of infant deaths from 2016-2020.

Top of Page

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.